Cheng Andrew bought DMRA
August 12, 2026 · Form 4 insider transaction
Cheng Andrew bought 30,350 shares of Damora Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
30,350
Price
$0.00
Total value
N/A
InsiderCheng Andrew
RoleOfficer, Director
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateAugust 12, 2026
Filing dateAugust 13, 2026
Shares owned after30,350
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option represents a right to purchase shares of common stock of the Issuer. This option will vest in equal monthly installments through August 12, 2029, subject to the Reporting Person's continued service to the Issuer on each such vesting date.